Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 30, 2025 06:00 ET | Source: Er-Kim Pharmaceuticals

Er-Kim Announces Exclusive Distribution Agreement with Puma Biotechnology to Commercialize NERLYNX® (neratinib) for Breast Cancer Patients

Er-Kim and Puma Biotechnology sign agreement to commercialize NERLYNX® (neratinib) in select countries in Eastern Europe and Central Asia
October 30, 2023 09:07 ET | Source: INmune Bio, Inc.

INmune Bio Inc. Presents Preclinical Data at SITC 2023 Showing INB03 is an Innate Immune Check Point Inhibitor that Downregulates SIRPα

SIRP-CD47 is an innate immune checkpoint known as the “don’t eat me” signal. INB03 downregulates expression of SIRPα on macrophages promote increased cancer cell death by antibody dependent cellular...
February 09, 2023 18:00 ET | Source: Whittier Street Health Center

Whittier Street Health Center Awarded a Grant to Expand Breast Cancer Services as Part of President's Reignited Cancer Moonshot, the Biden-Harris Administration Awards

BOSTON, Feb. 09, 2023 (GLOBE NEWSWIRE) -- A $500,000 grant was awarded to Whittier Street Health Center to expand its breast cancer screening program, in partnership with Dana-Farber Cancer...
January 24, 2022 07:43 ET | Source: US Capital Global

QT Imaging, Inc. Reaches New Milestones with Its Breakthrough Ultrasound Technology for Breast Imaging

San Francisco, California, USA, Jan. 24, 2022 (GLOBE NEWSWIRE) -- Last year, US Capital Global Securities LLC, an affiliate of US Capital Global, launched a convertible note offering of up to $30...
December 09, 2021 09:01 ET | Source: INmune Bio, Inc.

INmune Bio, Inc. Announces Key Breast Cancer Treatment Resistance Data to be Presented at the 2021 San Antonio Breast Cancer Symposium

Data suggests in triple negative breast cancer that MUC4 predicts survival and resistance to immunotherapy and that INB03 reverses resistance by decreasing immunosuppression in the TME Boca...